Clinical Trial Update: Prevention of Recurrence of Crohn's Disease by Fecal Microbiota Therapy (FMT) [Phase 2]

View source ↗

Summary

Phase 2 trial on fecal microbiota therapy (FMT) to prevent recurrence of Crohn's disease; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Snippet

Sponsor: Boston Medical Center | Conditions: Crohn's Disease | Phase 2 | Status: TERMINATED | Results posted: 2022-03-24